AV
Ashwani Verma UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
46
Avg Return
Past Year
Past Year
5.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
53.8%
Neutral
46.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $215 |
33%
upside
| 1 | -7.9% |
0
%
| 6 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $645 |
39%
upside
| 2 | +9% |
0
%
| 6 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $248 |
40%
upside
| 1 | +3.4% |
0
%
| 6 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $40 |
54%
upside
| 1 | +13% |
0
%
| 6 Jan ‘26 12 days ago |
|
|
|
Neutral
Initiated
| $95 |
174%
upside
| 1 | – |
–
| 16 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $48 |
117%
upside
| 1 | -22% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $11 |
16%
downside
| 1 | -32% |
0
%
| 26 Nov ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $188 |
11%
upside
| 1 | +30% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $10 |
103%
upside
| 1 | -4.3% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $220 |
3%
upside
| 1 | – |
–
| 7 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $40 |
9%
downside
| 1 | – |
–
| 6 Nov ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $20 |
7%
downside
| 1 | +30% |
0
%
| 28 Oct ‘25 2 months ago |
|